These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9077508)

  • 1. Extra-muscle involvement in dystrophinopathies: an electroretinography and evoked potential study.
    Girlanda P; Quartarone A; Buceti R; Sinicropi S; Macaione V; Saad FA; Messina L; Danieli GA; Ferreri G; Vita G
    J Neurol Sci; 1997 Mar; 146(2):127-32. PubMed ID: 9077508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations.
    Pillers DA; Fitzgerald KM; Duncan NM; Rash SM; White RA; Dwinnell SJ; Powell BR; Schnur RE; Ray PN; Cibis GW; Weleber RG
    Hum Genet; 1999; 105(1-2):2-9. PubMed ID: 10480348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroretinogram in Duchenne/Becker muscular dystrophy.
    Pascual Pascual SI; Molano J; Pascual-Castroviejo I
    Pediatr Neurol; 1998 Apr; 18(4):315-20. PubMed ID: 9588526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERG phenotype of a dystrophin mutation in heterozygous female carriers of Duchenne muscular dystrophy.
    Fitzgerald KM; Cibis GW; Gettel AH; Rinaldi R; Harris DJ; White RA
    J Med Genet; 1999 Apr; 36(4):316-22. PubMed ID: 10227401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophin expression in the human retina is required for normal function as defined by electroretinography.
    Pillers DA; Bulman DE; Weleber RG; Sigesmund DA; Musarella MA; Powell BR; Murphey WH; Westall C; Panton C; Becker LE
    Nat Genet; 1993 May; 4(1):82-6. PubMed ID: 8513332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between electroretinographic findings, clinical phenotypic and genotypic analysis in Duchenne and Becker muscular dystrophy].
    Yang Y; Zhang C; Sheng W; Pan S; Wu D; Jiang F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Feb; 18(1):32-4. PubMed ID: 11172639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the ocular phenotype of Duchenne and Becker muscular dystrophy.
    Sigesmund DA; Weleber RG; Pillers DA; Westall CA; Panton CM; Powell BR; Héon E; Murphey WH; Musarella MA; Ray PN
    Ophthalmology; 1994 May; 101(5):856-65. PubMed ID: 8190471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
    Mizuno Y; Nonaka I; Hirai S; Ozawa E
    J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal evoked potentials in myotonic dystrophy (MyD).
    Cosi V; Bergamaschi R; Versino M; Callieco R; Sandrini G; Ruiz L
    Neurophysiol Clin; 1992 Mar; 22(1):41-50. PubMed ID: 1588901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dystrophin isoforms on signal transduction through neural retina: genotype-phenotype analysis of duchenne muscular dystrophy mouse mutants.
    Pillers DA; Weleber RG; Green DG; Rash SM; Dally GY; Howard PL; Powers MR; Hood DC; Chapman VM; Ray PN; Woodward WR
    Mol Genet Metab; 1999 Feb; 66(2):100-10. PubMed ID: 10068512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies.
    Sahashi K; Ibi T; Suoh H; Nakao N; Tashiro M; Marui K; Arahata K; Sugita H
    Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of dystrophin gene mutations on the ERG in mice and humans.
    Cibis GW; Fitzgerald KM; Harris DJ; Rothberg PG; Rupani M
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3646-52. PubMed ID: 8258524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
    Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
    Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystrophin immunofluorescence pattern in manifesting and asymptomatic carriers of Duchenne's and Becker muscular dystrophies of different ages.
    Vainzof M; Pavanello RC; Pavanello I; Tsanaclis AM; Levy JA; Passos-Bueno MR; Rapaport D; Zatz M
    Neuromuscul Disord; 1991; 1(3):177-83. PubMed ID: 1822792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study.
    Hoogerwaard EM; Bakker E; Ippel PF; Oosterwijk JC; Majoor-Krakauer DF; Leschot NJ; Van Essen AJ; Brunner HG; van der Wouw PA; Wilde AA; de Visser M
    Lancet; 1999 Jun; 353(9170):2116-9. PubMed ID: 10382696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal evoked potentials and electroretinography in limb girdle muscular dystrophy.
    Stübgen JP; Bartel PR
    Electromyogr Clin Neurophysiol; 1995; 35(1):31-8. PubMed ID: 7737013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Central nervous system involvements in Duchenne/Becker muscular dystrophy].
    Kumagai T; Miura K; Ohki T; Matsumoto A; Miyazaki S; Nakamura M; Ochi N; Takahashi O
    No To Hattatsu; 2001 Nov; 33(6):480-6. PubMed ID: 11725514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T; Stuettgen P; Cremer M; Goebel HH
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of deletions in the dystrophin gene in patients with Duchenne muscular dystrophy in the Bashkir Republic].
    Grinchuk OV; Khidiiatova IM; Kiselev AV; Magzhanov RV; Khusnutdinova EK
    Genetika; 1999 Apr; 35(4):551-5. PubMed ID: 10420280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cysteine 3340 substitution in the dystroglycan-binding domain of dystrophin associated with Duchenne muscular dystrophy, mental retardation and absence of the ERG b-wave.
    Lenk U; Oexle K; Voit T; Ancker U; Hellner KA; Speer A; Hübner C
    Hum Mol Genet; 1996 Jul; 5(7):973-5. PubMed ID: 8817332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.